personalized glp-1 + B12 Curious how custom GLP-1 weight

Available from: Cited 12/8/2025

The N -Fmoc protecting group was removed with 20% piperidine in DMF (3 mL) also with the standard methods

Received: Revised: Accepted: Published: Issue date: DOI:

Before starting GLP-1 therapy , patients should discuss their complete medical history with their healthcare provider, including the duration and stability of their Hashimoto's disease, current levothyroxine dose, most recent thyroid function tests, and any family history of thyroid cancer or MEN 2 syndrome

1 Monitor the patient on the day of the procedure for presence of any gastrointestinal symptoms (e.g., nausea and vomiting, bloating, abdominal pain) and adherence to holding the GLP-1 agonists as instructed